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Abstract
Background: Mutations in candidate genes that encode for a ligand (NDP) and receptor complex (FZD4, LRP5
and TSPAN12) in the Norrin β-catenin signaling pathway are involved in the pathogenesis of familial exudative
vitreoretinopathy (FEVR, MIM # 133780). Recently, a transcription factor (ZNF408) has also been implicated in FEVR.
We had earlier characterized the variations in NDP among FEVR patients from India. The present study aimed at
understanding the involvement of the remaining genes (FZD4, TSPAN12 and ZNF408) in the same cohort.
Methods: The DNA of 110 unrelated FEVR patients and 115 unaffected controls were screened for variations in the
entire coding and untranslated regions of these 3 genes by resequencing. Segregation of the disease-associated
variants was assessed in the family members of the probands. The effect of the observed missense changes were
further analyzed by SIFT and PolyPhen-2 scores.
Results: The screening of FZD4, TSPAN12 and ZNF408 genes identified 11 different mutations in 15/110 FEVR probands.
Of the 11 identified mutations, 6 mutations were novel. The detected missense mutations were mainly located in the
domains which are functionally crucial for the formation of ligand-receptor complex and as they replaced evolutionarily
highly conserved amino acids with a SIFT score < 0.005, they are predicted to be pathogenic. Additionally 2 novel and
16 reported single nucleotide polymorphisms (SNP) were also detected.
Conclusions: Our genetic screening revealed varying mutation frequencies in the FZD4 (8.0 %), TSPAN12 (5.4 %)
and ZNF408 (2.7 %) genes among the FEVR patients, indicating their potential role in the disease pathogenesis.
The observed mutations segregated with the disease phenotype and exhibited variable expressivity. The mutations in
FZD4 and TSPAN12 were involved in autosomal dominant and autosomal recessive families and further validates the
involvement of these gene in FEVR development.
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Background
FEVR is a potentially blinding eye disorder caused by
mutations in genes that play a crucial role in the devel-
opment of the normal retinal vasculature [1–10]. It is
primarily characterized by a failed development of the
peripheral retinal vasculature on the temporal side of
the retina [11–13]. This feature is asymptomatic and ob-
served in most patients without any further progression
during their life time [7, 11, 12]. However, it might lead
to secondary clinical complications including neovascu-
larization, retinal traction with ectopic macula, exud-
ation, subtotal and total retinal detachment in some
patients [7, 11, 12]. The age of onset in FEVR is variable
but the severe disease phenotype is usually observed in
the first or second decade of a patient's life. A highly vari-
able expressivity between the two eyes of the same patient
and among the different family members is another com-
monly reported feature of this disease [7, 11, 12].
So far, mutations in 6 candidate genes have been attrib-
uted to the development of FEVR including Norrie disease
pseudoglioma (NDP; OMIM 300658) [1, 9, 10, 14, 15],
Frizzled-4 (FZD4; OMIM 604579) [1, 2, 7, 8, 14–20], Low
* Correspondence: inderjeet@lvpei.org; ikaurs@gmail.com
1Kallam Anji Reddy Molecular Genetics Laboratory, Brien Holden Eye
Research Centre, L V Prasad Eye Institute (KAR Campus), Road#2, Banjara Hills,
Hyderabad 500034, India
Full list of author information is available at the end of the article
© 2016 Musada et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Musada et al. BMC Ophthalmology  (2016) 16:90 
DOI 10.1186/s12886-016-0236-y
density lipoprotein receptor like protein 5 (LRP5; OMIM
603576) [1, 2, 6, 14–16, 19, 21], Tetraspanin-12 (TSPAN12;
OMIM 613138) [1, 2, 4, 5, 22–25], Zinc finger prortein-
408 (ZNF408) [1, 3] and Kinesin family member 11
(KIF11) [26, 27]. Mutations in these genes have resulted in
autosomal dominant (FZD4, LRP5, TSPAN12, ZNF408
and KIF11)[[3, 7, 8, 14–16, 24, 26, 27], autosomal reces-
sive (LRP5, TSPAN12) [21, 23] and X-linked (NDP)
FEVR [9, 10] and have accounted for ~50 % of all pa-
tients [1–3]. Among these, the autosomal dominant
mode of inheritance has been widely reported. The pro-
teins encoded by FEVR candidate genes (excluding
ZNF408 and KIF11) have been shown to be involved in
the formation of a signal transduction complex of Norrin-
β catenin signaling pathway [28–32]. The knockout mouse
models of these genes have exhibited phenotype resem-
bling FEVR and have provided further evidence on the role
of this signaling pathway in the formation, maturation and
maintenance of intraretinal vasculature [28–31, 33–37].
Norrin, a protein encoded by NDP gene being similar to
canonical-Wnt signaling pathway, acts as a ligand and
interacts with FZD4-LRP5 receptor complex. This inter-
action further stabilizes the cytoplasmic β catenin mole-
cules to induce the T-cell factor/lymphoid enhancer factor
(TCF/LEF) mediated gene expression after its transloca-
tion into the nucleus [30–32]. TSPAN12 enhances the
Norrin signaling by augmentation of FZD4 multimeriza-
tion [28]. However, the roles of the ZNF408 and KIF11
genes in the developmental retinal angiogenesis and Nor-
rin- β catenin signaling pathway is yet unknown.
The FZD4 is a 537 amino acid protein containing an N-
terminal extracellular domain (composed of signal se-
quence, FZ domain and a linker region), 7 transmembrane
hydrophobic helical domains, 3 extracellular, 3 intracellular
loops and a C terminal cytoplasmic domain [38, 39]. The
extracellular FZ domain is cysteine rich (CRD) and is es-
sential for the recognition and binding to FZD4 specific li-
gands [40, 41]. The cytoplasmic C terminal region contains
two highly conserved PDZ binding domains (postsynaptic
density 95/disc-large/zona occludens-1: KTXXXW and
ETVV) and play a crucial role in recruiting downstream
regulator proteins to induce the signaling mechanism [39].
The TSPAN12 gene is located on chromosome 7q31 and
encodes for a 305 amino acid transmembrane protein.
Structurally, this protein contains four transmembrane do-
mains connected by two extra cellular loops (ECL-1 and 2)
and an intra cellular loop, and intracellular N and C termi-
nals. The ECL-1 is small compared to the ECL-2 [4, 5, 22].
Recently, Collin et al. [3] functionally characterized this
new candidate gene ZNF408 in FEVR. A novel founder
mutation was observed in two Dutch families and further
screening of 132 patients revealed another mutation in a
Japanese patient. The ZNF408 gene encodes for a 720
amino acid protein and predicted to contain ten zinc finger
DNA binding domains. Based on the presence of zinc fin-
ger domains, this protein was suggested to be a transcrip-
tion factor [3]. Functional analysis of mutant proteins
indicated a dominant negative disease mechanism and sub-
sequent knockdown of Znf408 in zebrafish, suggested its
putative role in retinal vasculogenesis.
So far, 88 different mutations have been reported in
FZD4 (n = 58), TSPAN12 (n = 27) and ZNF408 (n = 3) in
patients with FEVR and other vitreo-retinal abnormalities.
These genes have been quite well characterized in Cauca-
sian, Chinese and Japanese FEVR patients. However, in the
Indian context, there is only a single report from a relatively
smaller cohort of FEVR patients on FZD4 gene screening
[42] (Nallathambi J et al.,). Thus, the present study was
undertaken to explore the involvement of the FZD4,
TSPAN12 and ZNF408 genes and to assess their mutation
spectrum in a large cohort of Indian FEVR patients.
Methods
The study was approved by the Institutional Review Board
(IRB) of L.V. Prasad Eye Institute, Hyderabad, India, (Ref
no LEC06104) and adhered to tenets of the Declaration of
Helsinki. We recruited 110 unrelated FEVR cases (34 fa-
milial and 76 sporadic) along with their family members
after obtaining a written informed consent. All the patients
had a history of full term birth. A senior ophthalmologist
examined all the patients and diagnosed the disease based
on indirect ophthalmoscopic examination, B-scan ultra-
sonography and fundus fluorescein angiography in select-
ive patients. As described previously, the diagnosis of
FEVR was confirmed based on the presence of bilateral
peripheral retinal avascularity along with or without any of
the ocular features such as subretinal exudation, neovascu-
larization, vitreoretinal traction, retinal folds, ectopic mac-
ula and partial or total retinal detachments [7, 12, 20]. The
different stages of the disease were ascertained based on
the Pendergast and Trese classification [12]. The diagnosis
and staging of the disease was independently confirmed by
another ophthalmologist through evaluation of the med-
ical records and fundus photographs of the patients. Add-
itionally, 115 ethnically matched normal subjects aged
over 60 years and without any present and past history of
retinal disorders nor signs or symptoms of FEVR or any
other ocular or systemic conditions were enrolled as con-
trols. They were generally subjects with senile cataract
who were also evaluated for any other ocular complica-
tions through a comprehensive eye examination.
Mutation screening of the FZD4 and TSPAN12 genes
Genomic DNA was extracted from peripheral blood leu-
cocytes using standard protocols of Phenol-Chloroform
extraction method [43]. Mutation screening of entire
coding and intron-exon boundaries of FZD4, TSPAN12
and ZNF408 genes were accomplished by polymerase
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chain reaction (PCR) based amplification of these re-
gions with 26 different sets of overlapping primers
followed by resequencing on an automated DNA se-
quencer ABI 3130 XL (Applied Biosystems, Foster City,
CA) using the Big Dye chemistry (version 3.1) following
the manufacturer’s guidelines. The primers used for PCR
and their optimum annealing temperatures are listed in
Additional file 1: Table S1. The observed variations were
further validated by resequencing. Samples of the avail-
able family members of the respective probands in the
FEVR-affected families were also screened for assessing
the segregation of the identified variations. In addition
to the screening of the observed variants in the ethnic-
ally matched controls, their allele frequencies were also
checked in the dbSNP [44], ESP5400 [45], NIEHS95 [46]
and ExAC [47] databases. All the identified non-
synonymous substitutions were assessed to predict their
functional significance by computational prediction
algorithims; SIFT [48], PolyPhen-2 [49], and Mutation
Taster [50]. Multiple sequence alignments were carried
out using Clustal W to determine the evolutionary con-
servation of wild type amino acid residues at the position
of substitutions [51]. Evolutionarily non-conservative mis-
sense changes predicted as deleterious by at least two
computational tools were considered as potentially patho-
genic mutations. The remaining missense changes were
categorized as variants of unknown significance.
Results
The screening of the entire coding and flanking regions of
FZD4, TSPAN12 and ZNF408 genes revealed a total of 11
potentially pathogenic mutations in 15 different FEVR pro-
bands (Table 1 and Fig. 1). Of these 11 mutations, six were
novel. The novel mutations included a missense change
(c.341 T >G; p.Ile114Ser), a single base pair insertion
(c.1395_1396insT; p.Arg466Serfs*6) and a non-stop change
(c.1613A >C; p.*538Serext*2) in the FZD4 gene. Three
novel mutations c.125 T >C (p.Val42Ala), c.479G >A
(p.Cys160Tyr) and c.2145G >T (p. Glu715Asp) were also
observed in theTSPAN12 and ZNF408, respectively (Table 1
and Fig. 1). In addition to these novel changes, two previ-
ously reported missense mutations; c.313A >G; [p.Met105-
Val] [1, 2, 16, 18, 20] and c.470 T >C [p.Met157Thr] [2],
two small base pair deletions; c.1282-1285delGACA
[p.Asp428Serfs*2] [1, 2, 15, 16] and c.1286-1290delAGTTA
[p.Lys429Argfs*28] [52] in the FZD4 gene; a rare variant in
TSPAN12 gene; c.334G >A [p.Val112Ile] and two novel
missense changes (c.130C >T [p.Pro44Ser] and c.694A >G
[p.Met232Val]) in ZNF408 of unknown significance were
also observed. None of these mutations were observed in
the 115 normal controls. Apart from these mutations,
three reported single nucleotide polymorphisms (SNPs);
c.502C > T [rs61735303], c.576C > T [rs2011686860] and
c.1078 A >G [rs530613772] were observed in FZD4 gene.
Two intronic (IVS2 + 24C > G [rs545602315] and IVS6
+ 19G > C) and five 3′ UTR single nucleotide substitu-
tions (c.*39C > T [rs41622], c.*334A > T [rs545129654],
c.*1010 T > G, c.*1140 T > A and c*1243A > T [rs1892
21112]) were observed in the TSPAN12 gene. Likewise,
two novel 5′ UTR variations (c. -214_-210delGAATC
and -111C > A) and six SNPs (c.402A > G [rs5613
20549], c.408C > A, c.576_587del12bp [rs148055528],
c.581_592del12bp [rs72461400] c.1971A > G [rs37653
6252] c.1850C > A [rs547169524] were observed in
ZNF408.
All the nucleotide changes observed in FZD4 gene were
heterozygous. Excluding the c.313A >G (p.Met105Val) and
c.1286-1290delAGTTA (p.Lys429Argfs*28) mutations, the
remaining mutations were observed in one proband each.
A missense p.Met105Val mutation was observed in
three different probands and likewise a frameshift
p.Lys429Argfs*28 mutation was observed in two differ-
ent probands. Interestingly, a FEVR proband harbored
two changes: c.1282-1285delGACA (p.Asp428Serfs*2) and
c.1613A > C (p.*538Serext*2) in the FZD4 gene.
In TSPAN12, two mutations c.125 T >C (p.Val42Ala)
and c.334G >A (p.Val112Ile) were identified in one pro-
band each, while the c.479G >A (p.Cys160Tyr) mutation
was observed in four different probands, wherein, two of
them harbored heterozygous changes and the remaining
were homozygous. The p.Val112Ile mutation has also been
identified in homozygous condition whereas, p.Val42Ala
mutation was observed in heterozygous condition. The
wild type valine residue at codon 42 was highly conserved
across different species. However, this change was pre-
dicted to be non-pathogenic by PolyPhen-2 whereas, Mu-
tation Taster and SIFT indicated for the harmful effect of
this substitution.
Three heterozygous missense changes (p.Pro44Ser,
p.Met232Val and p. Glu715Asp) identified in ZNF408,
were observed in one proband each. Of the total nine
missense changes identified in the present study, except
p.Pro44Ser and p.Met232Val changes of ZNF408, the
remaining were predicted as deleterious by at least two
computational prediction tools used for in silico analysis.
Furthermore, the wild type amino acids located at these
missense changes were highly conserved across different
species (Fig. 2). Thus, these missense changes were cate-
gorized as potentially pathogenic mutations, while the
p.Pro44Ser and p.Met232Val changes of ZNF408 were
variations of unknown significance.
Discussion
In the present study, several novel mutations (missense,
non-stop and insertion) were detected in the coding re-
gions of FZD4, TSPAN12 and ZNF408 genes among the
unrelated FEVR probands. None of these nucleotide
changes were observed in 115 ethnically matched controls
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and were not present in the dbSNP [44], ESP5400 [45],
NIEHS95 [46] and ExAC [47] databases. The probands
harboring the mutations in these genes exhibited severe
disease phenotype with neovascularization, falciform ret-
inal folds, exudative or tractional retinal detachments and
severe visual impairment. Some of these mutations were
also observed in the family members of the probands who
exhibited a highly variable phenotype based on indirect
ophthalmoscopic examination. The phenotype of the family
members ranged from normal retinal vascularization or
very mild avascularization to neovascularization, partial
and/or total retinal detachments with or without exudation.
Since, some of the asymptomatic family members with the
identified mutations were unavailable for fluorescein fundus
angiography, we could not rule out the possibility of miss-
ing very mild retinal vascular changes. The patients identi-
fied with FZD4 or TSPAN12 or ZNF408 mutations
exhibited classical clinical features of FEVR, but failed to
exhibit any genotype-phenotype correlation.
Mutations detected in the FZD4 gene
A total of 58 different mutations have been reported in
FZD4 in FEVR patients, including 30 missense muta-
tions, 10 deletions, 9 nonsense mutations and two singe
bp insertions [1, 2, 7, 8, 14–20, 42, 51–55]. A heterozy-
gous novel c.1395_1396insT (p.Arg466Serfs*6) change
resulting in a frame shift at codon 466 leading to a prema-
ture termination codon, was observed in a familial case of
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aNCBI Reference Sequences for FZD4, TSPAN12 and ZNF408 mRNA are NM_012193.2, NM_012338.3 and NM_024741.2 respectively. b NCBI Reference Sequences
for FZD4, TSPAN12 and ZNF408 proteins are NM_036325.2, NP_036470.1 and NP_079017.1 respectively. The effect of missense changes were predicted using SIFT,
PolyPhen-2 and Mutation Taster online prediction tools. In SIFT, the scores less than 0.05 were considered as damaging. In PolyPhen-2, the scores less than 0.5
were considered as disease causing
Musada et al. BMC Ophthalmology  (2016) 16:90 Page 4 of 12
FEVR (Fig. 1; family 2; II:1) that segregated in all the af-
fected family members. The proband and her female sib-
lings (II:1 and II:3) with this frameshift mutation
developed bilateral vitreo retinal traction and total retinal
detachment at their infancy while their mother (I:2) who
was a carrier for this mutation, had avascularized periph-
eral retina (Fig. 3). This is the third insertion mutation to
be observed in the FZD4 gene so far.
A novel non-stop change (c.1613A > C; p.*538Serext*2)
along with a previously reported 4 base pair deletion
(c.1282-1285delGACA; p.Asp428Serfs*2) [1, 2, 15, 16] was
observed in a familial case in a compound heterozygous
condition. This change resulted in disruption of proper
termination and addition of two extra amino acids to the
wild type protein. A severe disease phenotype with bilat-
eral total retinal detachments was observed in the pro-
band (II:3) and her female sibling (II:1) that might have
resulted from the synergistic effect of both the mutated al-
leles. The father (I:1) and mother (I:2) of these siblings
were carriers for the mutated alleles c.1613A > C and
c.1282-1285delGACA, respectively The parents of these
siblings harboring either of the mutated alleles were nor-
mal or exhibited avascularized peripheral retina. The non-
stop mutation has been identified for the first time in
Fig. 1 Pedigrees of the FEVR families with nucleotide changes in FZD4 and TSPAN12 genes. Completely shaded symbols represent severe stages
of the disease. Open symbols represent unaffected individuals. Asterisk (*) over the pedigree symbols represent the individuals screened for
nucleotide changes in FZD4 and TSPAN12 genes. - indicates the presence of deletion/insertion and + indicates the wild type allele. The identified
nucleotide change is represented above each pedigree
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FZD4 gene and predicted to result in addition of two extra
amino acids to the C-terminal cytoplasmic domain of
FZD4 protein. Heterozygous compound mutations have
previously been reported in FZD4 gene and could explain
the inter and intra familial variability of disease phenotype
[18, 20]. The c.1282-1285delGACA change led to an open
reading frame alteration at codon 428 and formation of a
new stop codon at position 430.
The third frameshift heterozygous alteration c.1286-
1290delAGTTA (p.Lys429Argfs*28) was observed in two
unrelated probands in families 4 and 5 (Fig. 1; family 4; II:2
and family 5; II:1). Both the probands developed total ret-
inal detachment in one eye during early childhood and the
affected eyes developed subtotal retinal detachment exclud-
ing the fovea. The mother (I:2) of the proband 5 who was a
carrier for this deletion exhibited peripheral retinal
Fig. 2 Multiple sequence alignment showing the conservation of wild type residues in respect to identified missense changes in FZD4 protein,
TSPAN12, and ZNF408 across various species. Except p.M232V of ZNF408 remaining all the missense mutations were highly conserved across
different species. Reference sequences of the FZD4 orthologues: Homo sapiens; AAR23924.1, Macaca mulatta; NP_001253804.1, Rattus norvegicus;
NP_072145.1, Mus musculus; NP_032081.3, Gallus gallus; NP_989430.1, Xenopus laevis; NP_001083922.1, Canis lupus familiaris; XP_005633439.1,
Equus caballus; XP_001489854.1, Elephantulus edwardii; XP_006895316.1, Alligator mississippiensis; XP_006261662.1, Bos taurus; NP_001193198.1,
Lipotes vexillifer; XP_007448903.1, Sus scrofa; XP_005667267.1. Reference sequences of the ZNF408 orthologues: Homo sapiens; NP_079017.1,
Macaca mulatta; XP_001111210.1, Felis catus; XP_003993266.1, Canis lupus familiaris; XP_003639743.3, Equus caballus; XP_001490832.1, Pantroglodytes;
JAA35243.1 Bos taurus; NP_001180086.1, Callithrix jacchus; XP_009006283.1, Condylura cristata; XP_004683622.1, Sus scrofa; XP_013849819.1, Elephantulus
edwardii; XP_006896777.1
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avascularization while the proband’s father (I:1) despite hav-
ing a single copy of the mutant allele did not exhibit any
retinal vascular abnormality upon indirect ophthalmoscopy
examination. This deletion led to frameshift at codon 429
along with the formation of a premature stop codon.
All the three frameshift mutations (p.Arg466Serfs*6,
p.Asp428Serfs*2 and p.Lys429Argfs*28) were predicted
to result in the formation of a truncated protein with a
loss of 13 to 20 % of the wild type FZD4 protein. Due to
the presence of only two exons in FZD4, the frameshift
mutations observed in the second exon may result in
the formation of truncated protein rather than non-
sense mediated mRNA decay [56]. The resulting trun-
cated proteins affected the conserved KTXXXW
domain and PDZ binding motif, essential for inter-
action with downstream regulator proteins. In the ab-
sence of these motifs, FZD4 would likely fail to
induce the signaling pathway and consequently lead
to haploinsufficiency. Alternatively, the truncated
protein may oligomerize with wild type protein and
become trapped in the endoplasmic reticulum as re-
ported in the p.Lys501fs*533 mutation producing a
dominant negative effect [57, 58].
Three missense mutations p.Met105Val, p.Ile114Ser
and p.Met157Thr identified in the present study in
FZD4 were located in the extracellular cysteine rich do-
main (CRD) of the gene. The wild type amino acid resi-
dues located at the 105, 114 and 157 codon positions
were experimentally found to be crucial for ligand bind-
ing during Norrin signal transduction [30, 40, 41]. A
novel heterozygous mutation, c.341 T > G (p.Ile114Ser)
was identified in a female proband (II: 1) of family 1
(Fig. 1). The proband was noticed to have bilateral nys-
tagmus with exudative retinal detachment including her
Fig. 3 Fundus photographs of the FEVR patients with novel nucleotide changes identified in the FZD4 gene. a&b Patient ID: family 1-II:1 (c.341 T > G);
Right and left eyes of proband of FEVR family 1 shows straightening of blood vessels and macular dragging toward inferotemporal area of the retina.
c&d Patient ID: family 2- II:1 (c.1395_1396insT); Right and left eyes of proband of FEVR family 2 shows macular dragging toward inferotemporal retina.
e&f Patient ID: family 3- II:3; Right and left eyes of proband of FEVR family 3 shows straightening of blood vessels, exudation and vitreoretinal traction
Musada et al. BMC Ophthalmology  (2016) 16:90 Page 7 of 12
macula at 8 months of age. The mother of the proband
(I: 2) also harbored this change but was found to be clin-
ically normal under indirect ophthalmoscopic examin-
ation (Fig. 3). Although, the p.Ile114Ser was identified in
the present study, Robitaille et al., [53] reported a
p.Ile114Thr mutation in a familial FEVR case with bilat-
eral retinal folds at 2 months of age. The isoleucine
residue at 114 codon position of FZD4 was highly con-
served across multiple vertebrate species (Fig. 2). Re-
placement of hydrophobic isoleucine with a hydrophilic
serine residue at codon 114 was predicted to have dam-
aging effect on protein function by three algorithms in
insilico analysis (Table 1). These findings provide evi-
dence for the possible involvement of p.Ile114Ser muta-
tion in disease pathogenesis.
Both the p.Met105Val and p.Met157Thr mutations have
been previously identified in the Caucasian and Asian
populations [1, 2, 16, 18, 20]. In the present study, we have
identified the replacement of methionine by threonine at
157 codon position in a sporadic case (Fig. 1; family 6; I:2)
with total retinal detachment in both eyes of the proband.
This patient was examined at the age of 35 years with rov-
ing movements in the right eye and bilateral ectopic mac-
ula towards the temporal side. Her two sons (II:3 and II:4)
were also examined and found to be clinically normal and
did not harbor the observed change. In addition to this
mutation, a missense change (c.694A >G; p.Met232Val) in
ZNF408 of unknown significance was also detected in the
proband and one of her son without any observable ret-
inal non perfusion, indicating that the p.Met157Thr was
mainly responsible for the disease phenotype in this fam-
ily. The methionine at 157 codon position precedes a cyst-
eine (codon 158), which is involved in the formation of a
disulfide bond crucial for structural maintenance of CRD
[39]. Based on this information, we speculate that the
altered solvent interactions of hydrophilic threonine in-
stead of hydrophobic methionine in M157T mutation
may interfere with the disulfide bridge formation by
following cysteine. Thus, the structural alteration caused
by this mutation may interfere with the ligand interaction
or FZD4 homodimer formation and could result in the
pathogenicity.
The recurrent heterozygous mutation c.313A > G
(p.Met105Val) was observed in 3 different sporadic
FEVR probands (Fig. 1; families 7, 8 and 9) with ad-
vanced stages of FEVR. All the probands having this
mutation developed falciform folds and tractional ret-
inal detachment either in one or both eyes within a
few months of their birth. Among the three families,
two of the mothers (Families 7 and 9; I: 2) and a sib-
ling of the proband 9 (II:1) failed to show severe ret-
inal abnormalities despite of harboring a single copy
of mutant allele. However, the mother of the proband
8 (I:2) showed peripheral retinal avascularization.
Notably, like the M157T, the M105V mutations also
affected a cysteine residue at codon 106 that plays a cru-
cial role in CRD structure formation via disulfide bridge
formation with another cysteine at codon 45. Replace-
ment of the highly conserved methionine at codon 105
with a valine residue led to severe impairment of FZD4
signaling (Fig. 2) [30]. This information strongly sug-
gested the pathogenic nature of this missense mutation.
Mutations detected in the TSPAN12 gene
So far, 27 different mutations in TSPAN12 have been re-
ported in FEVR patients [1, 2, 4, 5, 22–25, 59]. These mu-
tations included missense, nonsense, small base pair
deletions, insertions and splice site mutations. A novel, het-
erozygous c.125 T >C (p.Val42Ala) missense mutation was
identified in a female proband (IV: 2) of a consanguineous
FEVR family 10 (Fig. 1). The proband developed bilateral
nystagmus along with attached retrolental membranes to
the posterior capsule and funnel shaped retinal folds at
4 months of age. This mutation was also observed in the
maternal uncle (III: 3) and aunt (III: 6) of the proband who
was reported to be blind since birth. However, both the
parents of the proband harboring this heterozygous change
were clinically normal. Another novel missense mutation
c.479G >A (p.Cys160Tyr) was identified in probands of
four unrelated FEVR families (Fig. 1; families 11 to 14). In
two probands (IV: 2) of consanguineous FEVR families (11
and 12), this mutation was found in a homozygous condi-
tion and showed autosomal recessive inheritance. The pro-
bands of the other two FEVR families (13 and 14) were
heterozygous for this change. The two probands having
homozygous mutation exhibited total retinal detachments
with a funnel shaped detached retinas within a few months
after birth. The probands with heterozygous mutation pro-
gressively developed exudative or tractional retinal detach-
ments with fibrovascular proliferations during the first or
second decades of their life (Fig. 4). The other members of
these families harboring this mutation showed variable
clinical expressivity that ranged from very mild peripheral
retinal non perfusion to exudation, falciform retinal folds
and total retinal detachments. The three prediction tools
used for insilico analysis indicated the damaging effect of
this non-conservative substitution on protein function.
The third missense mutation c.334G > A (p.Val112Ile)
was identified in homozygous condition in a male pro-
band of FEVR family 15. This patient was first examined
in our hospital at 24 years of age and found to have total
retinal detachment with falciform retinal folds in both
eyes with bilateral nystagmus at the initial examination
(Fig. 4). The mother and a male sibling of the proband,
who also harbored this mutation in heterozygous state,
were asymptomatic with mild pigmentary changes in the
retina. This change was previously reported in
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heterozygous condition as a rare variant by Exome Ag-
gregation Consortium with the frequency of minor allele
to be 0.0001 [47].
Another novel missense change, p.Cys160Tyr was
prevalent (3.6 % of the FEVR probands) in the present
study. This mutation was observed in the probands and
their affected family members of four unrelated FEVR
families (Fig. 1; families 11 to 14). Two severely affected
probands of the FEVR families (11 and 12) had homozy-
gous p.Cys160Tyr mutation while the remaining pro-
bands of two FEVR families (13 and 14) and their
affected relatives were heterozygous. Compared to pro-
bands with the homozygous mutations, the patients with
the heterozygous allele showed a slower progression of
the disease or relatively less severe ocular phenotype,
suggesting the recessive inheritance pattern of the dis-
ease and effect of allelic dosage on disease severity. The
previously described FEVR patients with homozygous
mutations in the candidate genes had severely reduced
protein expression that was shown to be responsible for
severity and rapid progression of the disease [21, 23, 60].
The p.Val42Ala mutation was located in the small extra-
cellular loop while, p.Val112Ile and p.Cys160Tyr muta-
tions were located in the large extracellular loop of the
protein. The wild type cysteine as seen for p.Cys160Tyr
mutation, is located at the second position in the highly
conserved CCG signature motif of extracellular loop 2
(ECL2) of the TSPAN12 protein (Fig. 2). This cysteine
residue was predicted to be involved in the formation of a
disulfide bridge with another cysteine residue located at
the 181 position of TSPAN12. The ECL2 was suggested
to be involved in protein-protein interactions with tar-
geted proteins in the cell membrane [61]. Therefore,
the disrupted structure of ECL2 due to p.Cys160Tyr
Fig. 4 Fundus photographs of the FEVR patients with novel nucleotide changes identified in the TSPAN12 gene. a&b Patient ID: family 14-III:2
(c.479G > A); a right eye of the proband of FEVR family 14 shows slightly dragged macula. b left eye of the proband of FEVR family 14 shows
avascular peripheral retina and exudation. c&d Patient ID: family 14-III:4 (c.479G > A) right and left eye of a family member of FEVR family 14 shows
avascular peripheral retina and scars of laser photocoagulation treatment. e&f Patient ID: family 15-IV:2 (c.334G > A) right and left eyes of proband
of FEVR family 15 shows straightening of blood vessels, retinal pigmentation, dragged macula and exudation
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mutation could probably interfere in TSPAN12 inter-
action with FZD4 protein, thereby affecting the Norrin-
FZD4 signaling.
Mutations detected in the ZNF408 gene
A novel, heterozygous, c.130C > T (p.Pro44Ser) change
was observed in a male proband (II: 2) of FEVR family 16
(Fig. 5). The proband had bilateral total retinal detach-
ments with retrolental membranes at 2 months of age.
The father of the proband (I: 2) was found to be normal
both phenotypically and genotypically while the mother (I:
1) remained unavailable for genetic analysis. All the three
algorithims predicted it to be of benign nature. The sec-
ond novel heterozygous c.2145G > T (p.Glu715Asp)
change was observed in a sporadic proband of FEVR fam-
ily 17. The proband exhibited total retinal detachment in
the right eye and subtotal retinal detachment including
macula in the left eye at one year of age. The mother of
the proband (I: 2) was found to be clinically normal with-
out this variation, while the father (I: 1) was unavailable
for genetic analysis. A previously reported T617N change
located in tenth zinc finger domain of the protein was also
observed in a family, which could potentially interfere
with DNA interaction. However, the presence of this
change in the unaffected mother of the proband and in a
control individual is suggestive for a less or non patho-
genic nature of this variation. In family 6, the proband had
M232V missense change in the ZNF408 gene and also a
heterozygous M157T mutation in FZD4 gene. The hetero-
zygous M232V change was also observed in one of the
two unaffected sons of the FEVR proband (Fig. 5) how-
ever, but they lacked the M157T mutation of FZD4. The
data thus suggested that M157T mutation was mainly re-
sponsible for the ocular phenotype in the proband. Fur-
ther structural and functional studies are required to
understand the effect of these missense changes on
ZNF408 protein and its downstream interactions.
Of the three novel non-synonymous variations ob-
served in the recently identified ZNF408 gene, the
p.Pro44Ser and p.Met232Val changes were predicted to
be harmless by the three algorithms used in in silico ana-
lysis and were considered as variations of unknown sig-
nificance, while an evolutionarily non-conservative
substitution p.Glu715Asp was predicted to be patho-
genic (Fig. 2). None of these changes were seen in the
controls (Table 1).
Interestingly, none of the variations in ZNF408 gene in
our Indian cohort were observed in the Caucasian and
Asian FEVR patients indicating the allelic heterogeneity
of this condition. In summary, the present study pro-
vides an independent validation of the involvement of
ZNF408 in FEVR from an ethnically diverse population
from India. This also expands the mutation spectrum of
ZNF408 in the pathogenesis of FEVR that would need to
be further supplemented with diverse data from other
populations.
Fig. 5 Pedigrees of the FEVR families with nucleotide changes in ZNF408 gene. Completely shaded symbols represent severe stages of the
disease. Open symbols represent unaffected individuals. Asterisk (*) over the pedigree symbols represent the individuals screened for nucleotide
changes in ZNF408 gene. - indicates the presence of deletion/insertion and + indicates the wild type allele. The identified nucleotide change is
represented above each pedigree
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Conclusion
In summary, the mutation frequencies of the 3 candidate
genes among the Indian FEVR patients were comparable to
previous reports in FZD4 (3.5–40 %) [1, 2, 7, 8, 14–20, 42],
and TSPAN12 (3.5–10 %) [1, 2, 4, 5, 22–25] genes in differ-
ent populations. In previous reports the frequency of FEVR
patients with ZNF408 mutations varied from 0 to 1.8 % in
different populations [1–3]. The frequency of patients with
FZD4 mutations in our cohort was relatively higher when
compared to a previous study by Nallathambi et al., in an-
other cohort of Indian FEVR patients [42]. This indicates
the broad spectrum of FZD4 mutations in FEVR pathogen-
esis among the Indian patients. Other than the common
ocular features of FEVR, we did not recognize any distin-
guishable features specific to the cases harboring FZD4,
TSPAN12 and ZNF408 mutations in these patients for
undertaking genotype-phenotype correlation. The novel
mutations identified in the present study further broadened
the mutation spectrum in FEVR patients, which would fa-
cilitate better genetic counseling and diagnostics to treat
these patients before the development of severe visual
complications.
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